Voting Rights and Shares Capital of the Company
PremiumPress ReleasesVoting Rights and Shares Capital of the Company
2M ago
Nanobiotix initiated with a Buy at Stifel
Premium
The Fly
Nanobiotix initiated with a Buy at Stifel
2M ago
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Premium
Press Releases
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
3M ago
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
PremiumPress ReleasesNANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
4M ago
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Premium
Press Releases
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
5M ago
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
Premium
Press Releases
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100